CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification.

Autor: Okoye AA; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Duell DD; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Fukazawa Y; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Varco-Merth B; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Marenco A; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Behrens H; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Chaunzwa M; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Selseth AN; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Gilbride RM; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Shao J; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Edlefsen PT; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Geleziunas R; Gilead Sciences, Inc., Foster City, California, USA., Pinkevych M; Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, New South Wales, Australia., Davenport MP; Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, New South Wales, Australia., Busman-Sahay K; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Nekorchuk M; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Park H; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Smedley J; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Axthelm MK; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Estes JD; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Hansen SG; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Keele BF; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.; Leidos Biomedical Research, Inc., Frederick, Maryland, USA., Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.; Leidos Biomedical Research, Inc., Frederick, Maryland, USA., Picker LJ; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2021 Apr 15; Vol. 131 (8).

Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir.

Autor: Keele, Brandon F.¹ (AUTHOR) brandon.keele@nih.gov, Okoye, Afam A.² (AUTHOR), Fennessey, Christine M.¹ (AUTHOR), Varco-Merth, Benjamin² (AUTHOR), Immonen, Taina T.¹ (AUTHOR), Kose, Emek¹ (AUTHOR), Conchas, Andrew¹ (AUTHOR), Pinkevych, Mykola³ (AUTHOR), Lipkey, Leslie¹ (AUTHOR), Newman, Laura¹ (AUTHOR), Macairan, Agatha¹ (AUTHOR), Bosche, Marjorie¹ (AUTHOR), Bosche, William J.¹ (AUTHOR), Berkemeier, Brian¹ (AUTHOR), Fast, Randy¹ (AUTHOR), Hull, Mike¹ (AUTHOR), Oswald, Kelli¹ (AUTHOR), Shoemaker, Rebecca¹ (AUTHOR), Silipino, Lorna¹ (AUTHOR), Gorelick, Robert J.¹ (AUTHOR)

Publikováno v: PLoS Pathogens. 4/9/2024, Vol. 20 Issue 4, p1-29. 29p.

Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination.

Autor: Nel, Carla, Frater, John

Publikováno v: Frontiers in Immunology; 2024, p1-18, 18p

Generating and measuring effective vaccine-elicited HIV-specific CD8⁺ T cell responses.

Autor: Borgo, Gina M., Rutishauser, Rachel L.

Publikováno v: Current Opinion in HIV & AIDS; Nov2023, Vol. 18 Issue 6, p331-341, 11p

CD8 + T-cell responses in HIV controllers: potential implications for novel HIV remission strategies.

Autor: Rutishauser, Rachel L., Trautmann, Lydie

Publikováno v: Current Opinion in HIV & AIDS; Sep2022, Vol. 17 Issue 5, p315-324, 10p